Bioretec Oy
OMXH:BRETEC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hebei Sailhero Environmental Protection High-tech Co Ltd
SZSE:300137
|
CN |
Bioretec Oy
Total Current Liabilities
Bioretec Oy
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bioretec Oy
OMXH:BRETEC
|
Total Current Liabilities
€1.8m
|
CAGR 3-Years
27%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
R
|
Revenio Group Oyj
OMXH:REG1V
|
Total Current Liabilities
€25.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
7%
|
CAGR 10-Years
24%
|
|
|
M
|
Modulight Oyj
OMXH:MODU
|
Total Current Liabilities
€3.2m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
O
|
Optomed Oyj
OMXH:OPTOMED
|
Total Current Liabilities
€6.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
N
|
Nexstim Oyj
OMXH:NXTMH
|
Total Current Liabilities
€5.9m
|
CAGR 3-Years
19%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
B
|
Biohit Oyj
OMXH:BIOBV
|
Total Current Liabilities
€3.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
|
Bioretec Oy
Glance View
Bioretec Ltd. develops bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. The company is headquartered in Tampere, Lansi-Suomen. The company went IPO on 2021-09-28. The firm operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.
See Also
What is Bioretec Oy's Total Current Liabilities?
Total Current Liabilities
1.8m
EUR
Based on the financial report for Dec 31, 2025, Bioretec Oy's Total Current Liabilities amounts to 1.8m EUR.
What is Bioretec Oy's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
26%
Over the last year, the Total Current Liabilities growth was 37%. The average annual Total Current Liabilities growth rates for Bioretec Oy have been 27% over the past three years , 26% over the past five years .
